BSE filing, NSE: STALLION. Summary written from the filing by ALFA Finder's alert engine.
Stallion India Fluorochemicals Ltd: key numbers
- Share price
- ₹188.17
- Market cap
- ₹2,184 Cr
- Revenue (annual)
- ₹430.7 Cr
- Net profit (annual)
- ₹43.84 Cr
- P/E (TTM)
- 42.0×Sector 34.1×
- Promoter holding
- 47.80%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Stallion India Fluorochemicals Ltd
All →Stallion India Fluorochemicals Legal & Regulatory
Stallion India Fluorochemicals reported the completion of a Maharashtra GST inspection. The company has paid the resulting tax and interest liabilities with no material operational impact.
Stallion India Fluorochemicals Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI regulations.
Stallion India Fluorochemicals Management Change
Swati Ghosh has been regularised as a Non-Executive Independent Director at Stallion India Fluorochemicals Limited. This designation change was effective from September 21, 2026.
Stallion India Fluorochemicals Annual General Meeting
Stallion India Fluorochemicals held its 24th AGM on September 21, 2026, to discuss financial statement adoption and director appointments. Official results will be disclosed separately.
Stallion India Fluorochemicals Production Started
Stallion India Fluorochemicals has commenced commercial operations at its new Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra. The plant has an aggregate annual capacity of 1,200 MT.
- Semiconductor & Specialty Gas debulking & blending capacity
- 1200.0 MTPA
Stallion India Fluorochemicals Annual Report
Stallion India Fluorochemicals Ltd has filed its Annual Report for FY 2025-26 and notified the cut-off date for its 24th Annual General Meeting.
Other other announcement announcements
All →KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.